Another 2 NDA filings and 2-3 Partnerships coming this Year ..Only 20 M on the float .GLTA
IGXT has the Potential to hit $10++ within 2 Year ! GLTA
Market Cap : $28 M
Cash: $3 M
Burn-Rate : $1.2 M a year
Shares Out : 51 M ( 30 M shares are held by Investors )
unknown gem with brutal upside Potential........IGXT´s Monster Pipeline :
Product ......Application......... Status of Development
INT0004/2006 Antidepressant -- US launch in 4Q 2012
INT0008/2007 Migraine -- PDUFA Date on Feb 3 2014
INT0007/2006 Erectile Dysfunction -- NDA filing later in 2013
INT0001/2004 CHF (Coronary Heart Failure), Hypertension -- ANDA filing later in 2013
INT0027/2011 Undisclosed Partnered with Par Pharma -- ANDA filing later in 2013
INT0020/2010 Insomnia -- in Pivotal Study
INT0024/2010 Idiopathic pulmonary fibrosis -- in Pivotal Study
INT0028/2011 Cancer pain (cannabinoid) --in Pivotal Study
INT0030/2011 Animal health -- in Pivotal Study
INT0031/2012 Benign prostatic hyperplasia --in Pivotal Study
why would you write about IGXT on the SNTS message board area? were you born an idiot or has this been an acquired trait? too many exclamation points, too, BTW. you may wish to calm that down a bit.
NOBODY cares...go away
Dude! Stop pumping this #$%$!
Quebec companies never deliver! AEZS //// Go to hell.
Monster breakout to $1++ imminent folks ..glta